
CVS Health Corporation (CVS) Analyst/Investor Day December 9, 2025 8:00 AM EST
Company Participants
Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyner - President, CEO & Director Steven Nelson - Executive VP & President of Aetna Katerina Guerraz - Executive VP, COO & Director Sreekanth Chaguturu - President of Health Care Delivery & Executive VP Ed DeVaney - EVP & President of Cvs Caremark Pharmacy Benefit Management Business Lucille Accetta - Chief Pharmacy Officer Len Shankman - Executive VP and President of Pharmacy & Consumer Wellness Prem Shah - Executive VP & Group President Tilak M…

CVS Health Corporation (CVS) Analyst/Investor Day December 9, 2025 8:00 AM EST
Company Participants
Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyner - President, CEO & Director Steven Nelson - Executive VP & President of Aetna Katerina Guerraz - Executive VP, COO & Director Sreekanth Chaguturu - President of Health Care Delivery & Executive VP Ed DeVaney - EVP & President of Cvs Caremark Pharmacy Benefit Management Business Lucille Accetta - Chief Pharmacy Officer Len Shankman - Executive VP and President of Pharmacy & Consumer Wellness Prem Shah - Executive VP & Group President Tilak Mandadi - EVP of Ventures and Chief Experience & Technology Officer Brian Newman - Executive VP & CFO
Presentation
Operator
Please welcome Executive Vice President and Chief Strategy Officer, Larry McGrath.
Larry McGrath Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO
I haven’t done anything yet, but thank you. Good morning, everyone. Thanks for joining us for this CVS Health 2025 Investor Day. I think I know all of you in the room, but yes, I’m Larry McGrath. I have the privilege of leading our Strategy and Investor Relations functions here.
So first, on behalf of the entire CVS Health team, I’d like to extend a warm welcome to you all, either joining us here in person in Hartford or online through the webcast. We have an exciting day ahead of us today. Before we begin, I just have to remind you that our customary cautionary statements and safe harbors apply. You can see them here on screen. I’d also encourage you to consult our risk factors that we have on file with the SEC on our Form 10-K, 10-Q and 8-K.
All right, for our agenda, we’re going to start the day off. We’re very excited to have David come up and outline